Brentuximab vedotin for lymphoma in paediatric patients

Lancet Haematol. 2018 Oct;5(10):e433-e434. doi: 10.1016/S2352-3026(18)30160-1.
No abstract available

Publication types

  • Kommentar

MeSH terms

  • Brentuximab Vedotin
  • Child
  • Hodgkin Disease
  • Humans
  • Immunoconjugates*
  • Lymphoma*

Substances

  • Immunoconjugates
  • Brentuximab Vedotin